Trade Cronos Group Inc. - CRON
Cronos Group Inc., formerly known as PharmaCan Capital Corp., is a principal investment firm. The firm seeks to invest in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to Canada's Marihuana for Medical Purposes Regulations MMPR. The firm typically invests in companies based in Canada. The firm is primarily an equity investor, may also advance debt as appropriate. It seeks to make minority investments with appropriate governance and shareholder rights. The firm seeks board representation consistent with the size of the investment, but does not need control. Cronos Group Inc. was incorporated in January, 2013 and is based in Toronto, Canada with an additional office in Toronto, Canada.Latest shares articles

Allianz stock forecast: record H1 profit, Q3 earnings ahead
Allianz is a German insurer whose shares are trading near record levels following record first-half operating profit and reports of a possible €5.8 billion acquisition of AA. Explore third-party ALV targets and technicals. Past performance is not a reliable indicator of future results.
14 hours ago

Assicurazioni Generali stock forecast: rising bond yields, ECB outlook
Generali is an Italian insurer listed in Milan, with its shares recently trading amid rising eurozone bond yields and wider financial-sector activity in Italy. Explore third-party G price targets and technical analysis. Past performance is not a reliable indicator of future results.
19 hours ago

Amplifon stock forecast: H1 growth and margin outlook
Amplifon is an Italian hearing-care company listed on Borsa Italiana. Its pending GN Hearing acquisition remains a key focus as investors assess potential effects on growth, margins and debt. Explore third-party AMP price targets. Past performance is not a reliable indicator of future results.
20 hours ago

Uber Technologies stock forecast: 3,300 job cuts, robotaxi push
Uber is cutting around 3,300 jobs as part of a restructuring, while expanding its autonomous-vehicle partnerships amid growing competition in the robotaxi market. Explore third-party UBER price targets and technical analysis. Past performance is not a reliable indicator of future results.
13:42, 29 September 2026
Related News
Reuters News•Europe
Public Technologies•Europe
GlobeNewswire•Europe